A decade of experience with an inpatient pneumococcal vaccination program
- Pharmacists able to raise vax rate in high-risk patients. // PharmacoEconomics & Outcomes News;10/1/2011, Issue 638, p4
The article discusses a research study which revealed the success of U.S. pharmacists in identifying at-risk patients and offering additional immunization services, like the pneumococcal vaccine, published in the August 19, 2011 issue of the journal "Vaccine."
- Curbing a bacterial menace. Foster, Stephan L. // Pharmacy Today;Aug2010 Supplement, p5
In this article, the author offers his views on the role played by pharmacists in addressing the pneumococcal immunization gap and reducing the impact of this virulent bacterial threat in the U.S. He believes that pharmacists are in the best position to help increase pneumococcal vaccine uptake...
- Vaccination delivery by chain pharmacies in California: Results of a 2007 survey. Pilisuk, Tammy; Goad, Jeffery; Backer, Howard // Journal of the American Pharmacists Association: JAPhA;Mar/Apr2010, Vol. 50 Issue 2, p134
Objective: To better understand the practice standards and scope of pharmacist-administered vaccination services at chain pharmacies in California. Design: Cross sectional. Setting: California in 2006-2007. Participants: Eight state-level immunization coordinator corporate liaisons to chain...
- Introduction of pneumococcal vaccine to standard immunisation programmes in Europe: what are we waiting for? Heininger, Ulrich // European Journal of Pediatrics. Supplement;2002, Vol. 161, pS125
Focuses on the introduction of pneumococcal vaccine to standard immunization programs in Europe. Efficacy, efficiency and safety of pneumococcal conjugate vaccine.
- Similar antibody levels found among four PCV13 immunization schedules. // Infectious Disease News;Oct2013, Vol. 26 Issue 10, p48
The article discusses a study published in a 2013 issue of "JAMA: The Journal of the American Medical Association" that found similar antibody levels among 13-valent pneumococcal conjugate vaccine (PCV7) immunization schedules for infants.
- Vaccine Policy Decisions: Tension Between Science, Cost-Effectiveness and Consensus? Zimmerman, Richard Kent // American Family Physician;5/15/2001, Vol. 63 Issue 10, p1919
Editorial. Comments on the process used by the working group of the Advisory Committee on Immunization Practices to make policy recommendations for the use of pneumococcal conjugate vaccine. Focus of the working group and the data they have developed; Differences in the position of health...
- Vaccines. // Reactions Weekly;5/5/2012, Issue 1400, p38
The article describes the case of a 5-month-old boy with diffuse cutaneous mastocytosis who developed systemic, life-threatening generalised bullous eruption after he underwent routine immunisation with Haemophilus influenzae type B, conjugated pneumococcal vaccine, inactivated poliovirus...
- Immunization of Humans with Recombinant Pneumococcal Surface Protein A (rPspA) Elicits Antibodies That Passively Protect Mice from Fatal Infection with Streptococcus pneumoniae Bearing Heterologous PspA. Briles, David E.; Hollingshead, Susan K.; King, Janice; Swift, Amy; Braun, Patricia A.; Park, Moon K.; Ferguson, Laura M.; Nahm, Moon H.; Nabors, Gary S. // Journal of Infectious Diseases;12/1/2000, Vol. 182 Issue 6
Pneumococcal surface protein A (PspA), a cross-reactive protein expressed by all pneumo-cocci, is known to elicit an antibody in animals that can passively protect mice from infection with Streptococcus pneumoniae. A phase I trial with recombinant PspA showed the protein to be immunogenic in...
- Method for Ascertaining Denominators for Evaluation of Population Coverage with Pneumococcal Vaccine. Schopflocher, Donald P.; Russell, Margaret L. // Canadian Journal of Public Health;Sep/Oct2003, Vol. 94 Issue 5, p377
Background: Immunization programs may collect numerator data for the estimation of pneumococcal vaccine coverage, but program evaluators do not have appropriate denominator data for estimation of pneumococcal vaccine coverage, particularly among those eligible for vaccine on the grounds of...